Latest by Tim Murphy

Would You Treat Your HIV With a Monthly Injection Instead of Daily Pills?

Eight people living with HIV weigh in on an option that’s likely on its way.

By Tim Murphy

There Might Be an Alternative AIDS Conference in 2020

With powers-that-be set on hosting the biennial global AIDS summit in Trump's America, activists are already envisioning a boycott event in Mexico.

By Tim Murphy

You Up? This Public-Health Partner to Hookup Apps Sure Hopes So

Building Healthy Online Communities shows platforms like Grindr and Daddyhunt how to help users maintain sexual health.

By Tim Murphy

Disclosing One's HIV Status Is Still Hard, Even for People Who Work in HIV

"As people with HIV, we're always making and remaking this decision around disclosure."

By Tim Murphy

Eight HIV-Positive Folks Talk (Anonymously) About Why They Stay in the HIV Closet

Disclosing one’s HIV status in the workplace or in traditional and social media can have its pros and cons. It can make us feel freer and more empowered and help reduce societal HIV stigma – but in many places, it can still put us at risk for discrimina...

By Tim Murphy

California's Former ADAP Contractor Faces Lawsuit for an HIV Privacy Breach

The confidential medical records of at least 93 low-income Californians living with HIV were compromised, the suit alleges.

By Tim Murphy

A Cheaper Alternative to Truvada Is Hitting the Market: Here's Why It Might Not Lower Costs

Barring the unlikely event that a U.S. entity puts time and money into comparative trials, Cimduo can't cut into the PrEP portion of the Truvada market.

By Tim Murphy

Some Health Plans Are No Longer Counting Gilead's PrEP Copay Cards Toward Deductibles

Some private insurance plans are not counting copay assistance cards toward a person's deductible or out-of-pocket maximum. Depending on the plan design, this can have a significant impact on consumers.

By Tim Murphy

In the Era of Daily PrEP, Feds May Stop Research Funding Gels, Rings, and Douches for HIV Prevention

The effectiveness of pre-exposure prophylaxis has played a role in diverting U.S. funding from microbicide research.

By Tim Murphy